Press release
Meningococcal Vaccines Market is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% | Pfizer Inc., Bio-Med Pvt. Limited, Sanofi S.A., Chongqing Zhifei Biological Products Co., Ltd.
Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine market
This report contains a thorough analysis of the pre and post pandemic market scenarios. This report covers all the recent development and changes recorded during the COVID-19 outbreak
Request Free Sample Report at:
https://www.alliedmarketresearch.com/request-sample/330
Covid-19 scenario
Due to lockdown, immunization programs will come to a halt and program schedules will be changed in various countries.
Research and development activities for vaccine technology will be limited, as researchers need to stay at home during the lockdown.
Meningococcal vaccine is used as a placebo effect in the Covid-19 vaccine trial conducted at the University of Oxford.
Get detailed COVID-19 impact analysis on the Meningococcal Vaccine Market @
https://www.alliedmarketresearch.com/request-for-customization/330?reqfor=covid
Based on vaccine serotype, the majority of share was contributed by MenACWY vaccine segment. It accounted for nearly half of the total share in 2018, and is estimated to maintain its lead position during the forecast period. However, the MenA vaccine segment is anticipated to grow at the highest CAGR of 13.5% during the forecast period.
The conjugate segment to maintain its lead by 2026
Based on vaccine type, the conjugate segment held the largest share of the global meningococcal vaccine market, accounting for nearly half of the total market share in 2018, and is estimated to maintain its lead by 2026. Moreover, this segment is estimated to grow at the highest CAGR of 10.2% from 2019 to 2026. This is attributed to usage of vaccines in routine immunization schedules, preventive campaigns, and outbreak responses. The research also analyzes segments including polysachharide and subcapsular.
North America to maintain its dominance throughout the forecast period
Based on region, North America accounted for the largest market share in terms of revenue in 2018, holding nearly half of the global meningococcal vaccine market, and is estimated to maintain its lead position throughout the forecast period. This is due to surge in prevalence of meningitis disease and ease in availability of meningococcal vaccine products for treatment of the disease. However, Asia-Pacific is expected to portray the largest CAGR of 14.7% from 2019 to 2026, owing to surge in outbreaks of meningococcal diseases and widespread availability of products.
For Purchase Enquiry @
https://www.alliedmarketresearch.com/purchase-enquiry/330
Leading market players
Incepta Pharmaceuticals Ltd., Bio-Manguinhos, Pfizer Inc., Bio-Med Pvt. Limited, Sanofi S.A., Chongqing Zhifei Biological Products Co., Ltd., Serum Institute of India Pvt. Ltd., GlaxoSmithKline Plc., Walvax Biotechnology Co., Ltd., and Hualan Biological Engineering Inc.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% | Pfizer Inc., Bio-Med Pvt. Limited, Sanofi S.A., Chongqing Zhifei Biological Products Co., Ltd. here
News-ID: 2312441 • Views: …
More Releases from Allied Market Research
Insulation Coating Market to Grow at a Surprising CAGR of 5.9% by 2033
Allied Market Research published a report, titled, "Insulation Coating Market by Type (Acrylic, Epoxy, Polyurethane, YSZ, Mullite, Others), by End User (Aerospace, Automotive, Marine, Industrial, Building and Construction, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the "insulation coating market" was valued at $10.2 billion in 2023, and is estimated to reach $17.9 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.…
![[CAGR of 6.7%] Biocatalyst Market shows positive signs of growth with fastest CAGR by 2032](https://cdn.open-pr.com/L/1/L113826587_g.jpg)
[CAGR of 6.7%] Biocatalyst Market shows positive signs of growth with fastest CA …
Allied Market Research published a report, titled, "Biocatalyst Market by Source (Plant, Animal, Microorganism), By Type (Oxidoreductases, Transferases, Hydrolases, and Others), By End-Use Industry (pharmaceutical, food & beverage, water treatment, biofuel, and others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global biocatalyst industry was valued at $1.1 billion in 2022 and is estimated to reach $2.1 billion by 2032, exhibiting a CAGR of 6.7% from…
Carbon Filler Based Nanocomposite Market Insights, Trends and Forecast to 2033
A report by Allied Market Research provides an in-depth analysis of the competitive landscape in the carbon filler based nanocomposite industry, equipping key players with the insights needed to drive revenue growth and sustain a competitive edge. The report evaluates market dynamics and highlights strategic investment opportunities by utilizing analytical frameworks like Porter's Five Forces. It also offers data-driven guidance for strategic planning through key performance indicators such as CAGR…
Fluorite Market to Exhibit a Remarkable CAGR of 5.3% from 2025 to 2033
Allied Market Research published a report, titled, "Fluorite Market by Deposit Type (Hydrothermal Veins and Stockworks, Stratiform Replacement Deposits, and Others), Grade (Acid Grade Fluorite, Ceramic Grade Fluorite, and Metallurgical Grade Fluorite), and End-use Industry (Chemical Industry, Building Material Industry, Metallurgical Industry, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the "fluorite market" was valued at $3.6 billion in 2023, and is estimated to reach…
More Releases for Meningococcal
Impact Of Rising Healthcare Spending On Meningococcal Vaccines: An Emerging Driv …
The Meningococcal Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Meningococcal Vaccines Market Size and Projected Growth Rate?
The market size for meningococcal vaccines has seen rapid expansion in the past few years. The market is forecasted to increase from $3.89 billion…
Meningococcal Vaccines Market: Combating Life-Threatening Infections
In recent years, the global Meningococcal Vaccines Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Meningococcal Vaccines Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022
The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire…
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations…
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and…
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of…
